1 / 61

CIRRHOSIS OF LIVER

CIRRHOSIS OF LIVER . Dr.Vemuri Chaitanya. Cirrhosis. Chronic generalized liver disease A condition that is defined histopathologically and has a variety of clinical manifestations and complications, some of which can be life threatening.

kaethe
Download Presentation

CIRRHOSIS OF LIVER

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CIRRHOSIS OF LIVER Dr.Vemuri Chaitanya

  2. Cirrhosis • Chronic generalized liver disease • A condition that is defined histopathologically and has a variety of clinical manifestations and complications, some of which can be life threatening. • Pathologic features : development of fibrosis to the point that there is architectural distortion with formation of regenerative nodules ( micronodular / macronodular ) • This results in decrease in hepatocellular mass, thus function .

  3. NORMAL

  4. Micronodular Cirrhosis

  5. Macronodular Cirrhosis

  6. Epidemiology • 40% cases asymptomatic • It is the 12th leading cause of death in United States. • Approximately 30,000 to 50,000 deaths per year • Additional 10,000 deaths due to liver cancer secondary to cirrhosis

  7. This end stage of CLD is characterised by : • Bridging Fibrous Septa • Parenchymal nodules • Disruption of the architecture of the entire liver

  8. pathogenesis • Hepatocellular death • Regeneration • Progressive fibrosis • The induction of fibrosis occurs with activation of hepatic stellate cells, resulting in formation of increased amounts of collagen & other components of extracellular matrix. • Stimuli : 1.Chr.inflammation – cytokines like TNF, Lymphotoxin, IL-1 2.Cytokine production by injured Kupffer cells, endothelial cells, hepatocytes, bile duct epithelial cells 3.Disruption of ECM 4.Direct stimulation of stellate cells by toxins

  9. Etiology • Alcoholism • Chronic Viral Hepatitis – Hepatitis B Hepatitis C • Autoimmune Hepatitis • Nonalcoholic steatohepatitis • Biliary Cirrhosis – Primary biliary cirrhosis Primary sclerosing cholangitis Autoimmune cholangiopathy

  10. Etiology • Cardiac Cirrhosis • Budd Chiari Syndrome • Inherited metabolic liver disease : Hemochromatosis Wilson’s Disease Alpha 1 Antitrypsin deficiency Cystic Fibrosis • Cryptogenic Cirrhosis • Others : Galactosemia , Tyrosinemia, Drug induced : alpha methyldopa Syphilis

  11. Clinical Features • Asymptomatic for long periods. • Onset of symptoms – insidious , less often abrupt. • Non specific symptoms – vague right upper quadrant pain, fever, nausea, vomiting,diarrhea,anorexia & malaise. • Or they may present with more specific complication of CLD – ascites,upper GI bleed etc…

  12. Signs • Loss of hair ( alopecia ) • Icterus • Pallor • KF Ring • Parotid enlargement • Fetor hepaticus • Loss of axillary & pubic hair • Spider nevi • Gynecomastia • Atrophy of breasts in females • Wasting of muscles

  13. Signs • Glossitis, cheilitis • Palmar erythema • Clubbing • Leuconychia • Dupuytren’s contracture • Ascites • In 70 % cases liver is enlarged, firm if not hard and nodular • Splenomegaly • Caput medusae

  14. Signs • Bleeding tendencies : deficiency of clotting factors – check PT /INR • Fever • Hyperpigmentation • Hyperdynamic circulatory state • Edema • Hernia • Testicular atrophy • Delirium • Constructional apraxia • Flapping tremors • Inversion of sleep rhythm

  15. Palmar erythema

  16. Alcoholic Cirrhosis • Accurate history regarding amount & duration of alcohol consumption is required. • Lab tests : • Completely normal in early compensated alcoholic cirrhosis • Hb: Anemia + ( chr.GI loss, nutritional def, hypersplenism ) • Platelet count : reduced early in disease, portal htn with hypersplenism

  17. Alcoholic Cirrhosis • S.Bilirubin – normal / elevated • PT – often prolonged • S. Transaminases – elevated • AST / ALT = > 2/1 • Liver biopsy • Treatment : • Abstinence is the cornerstone of therapy. • Treatment of any complications • Glucocorticoids – if DF > 32 • Oral Pentoxiphylline

  18. Cirrhosis d/t Chr.Hepatitis B & C • Of patients exposed to HCV, approximately 80% develop Chronic hepatitis and of those, about 20 –30 % will develop cirrhosis over 20-30 yrs. • Here , liver is small & shrunken with a characteristic features of mixed micro and macro nodular cirrhosis seen on biopsy. • Of patients exposed to HBV, about 5 % develop chronic hepatitis & about 20% of those patients go on to develop cirrhosis. • Liver is small & shrunken and has mixed micro & macronodular cirrhotic pattern. • Invg : Routine investigations + HCV RNA, HBsAg, anti – HBs, HBeAg, anti – HBe, HEV DNA.

  19. Cirrhosis d/t Chr.Hepatitis B & C • Specific Treatment : • HBV : Lamivudine, Adefovir, Entecavir, Tenofovir • HCV: Pegylated Interferon, Ribavirin

  20. Primary Biliary Cirrhosis • Female preponderance • Median age of around 50 yrs • Etiology : unknown • Portal inflammation & necrosis of cholangiocytes in small and medium sized bile ducts. • Antimitochondrial antibodies in 90% of pts • Pathology : earliest lesion- Chronic Nonsuppurative Destructive Cholangitis

  21. Primary Biliary Cirrhosis • Fatigue • Pruritis • On ex: hepatomegaly splenomegaly ascites edema • Unique to PBC : Hyperpigmentation,Xanthelasma,Xanthomata

  22. Primary Biliary Cirrhosis LAB : • Elevated GGT, ALP with mild elevations of AST & ALT • Hyperbilirubinemia • Thrombocytopenia, leukopenia, anemia TREATMENT : • UDCA @ 13 – 15 mg/Kg per day • Liver Transplantation • Cholestyramine • Bisphosphonates – osteopenia/osteoporosis

  23. Primary Sclerosing Cholangitis • Etiology : unknown • Diffuse inflammation & fibrosis of entire biliary tree – chronic cholestasis – obliteration of intra & extrahepatic biliary tree – biliary cirrhosis – portal htn – liver failure • Cli fea : fatigue, pruritis, steatorrhea, fat sol vitamin deficiencies • Lab: 2 fold rise in ALP, elevated aminotransferases, p-ANCA ( 65%) • Diagnosis : MRCP , Cholangiogram • Treatment : No proven treatment. High dose 20 mg/kg/day UDCA. Endoscopic dilatation of dominant strictures Liver Transplantation

  24. Cardiac Cirrhosis • Pts with long standing right sided CHF may develop chronic liver disease & cardiac Cirrhosis • Cli fea : symptoms of Rt.Heart.Failure + Hepatomegaly • Lab : ALP raised, AST > ALT – normal / raised • Diagnosis : cardiac case with elevated ALP & enlarged liver

  25. Cirrhosis – other causes • Hemochromatosis • Wilson’s Disease • Alpha1 Antitrypsin Deficiency • Cystic Fibrosis

  26. Investigations • Complete Hemogram • Peripheral Smear • Platelet Count • PT INR • LFT – S. Bilirubin, S. Albumin, S. Globulin, SGPT, SGOT, ALP • Hepatitis Profile • Alpha Fetoprotein

  27. Investigations • Blood sugar • Urea, Creatinine • Sodium, Potassium • Ascitic fluid examination • X-Ray chest • USG / CT Abdomen • Confirmation by Liver Biopsy

  28. Complications of Cirrhosis • Portal HTN – Gastroesophageal Varices Portal hypertensive Gastropathy Splenomegaly, Hypersplenism Ascites – SBP • Hepatorenal Syndrome – Type 1 & 2 • Hepatic Encephalopathy • Hepatopulmonary Syndrome • Portopulmonary Hypertension • Malnutrition

  29. Complications of Cirrhosis • Coagulopathy : Factor deficiency Fibrinolysis Thrombocytopenia • Bone Disease : Osteopenia/Osteoporosis/ Osteomalacia • Haematological abn : Anaemia Hemolysis Thrombocytopenia Neutropenia

  30. Portal Hypertension • Prehepatic :Portal Vein thrombosis Splenic Veinf Thrombosis Massive Splenomegaly • Hepatic : Presinusoidal – Schistosomiasis Cong.hepatic fibrosis Sinusoidal – Cirrhosis Alcoholic hepatitis Postsinusoidal – Veno-occlusive Disease

  31. Posthepatic : Budd Chiari syndrome Inferior vena caval webs Cardiac Causes – Restrictive Cardiomyopathy Constrictive Pericarditis Severe CHF

  32. Portal Hypertension • Elevation of hepatic venous pressure gradient to > 5mm Hg. • It is caused by combination of 2 simultaneously occuring hemodynamic processes : • Increased intrahepatic resistance to passage of blood flow through liver • Increased splanchnic blood flow secondary to vasodilation.

  33. Portal Hypertension • Portal HTN directly responsible for 2 complications – variceal haemorrhage and ascites • Also hypersplenism, • congestive gastropathy, • renal failure and • hepatic encephaopathy

  34. CLINICAL FEATURES • Splenomegaly – Hypersplenism – Thrombocytopenia, Neutropenia, Anemia • Dilated Abdominal Veins, Caput Medusae, Ascitis. • Oesophageal varices

  35. Variceal Bleed • Approx 5 – 15 % of cirrhotics per year develop varices and it is estimated that majority of patients with cirrhosis will develop varices over their lifetime • 1/3rd of patients with varices develop bleeding. • Factors predicting variceal bleed : • Severity of cirrhosis ( Child’s Class ) • Ht of wedged hepatic vein pressure • Size and location of varix • Endoscopic stigmata : red wale sign, hematocystic spots, diffuse erythema, bluish color, cherry red spot & white nipple spot • Tense ascites

  36. Variceal Bleed • Diagnosis : identified by endoscopy • Pt with a gradient of >12 mm Hg – are at a greater risk for variceal bleed. • Precipitating Factors – Alcohol, Aspirin, Analgesics (NSAIDs), Adrenal Corticosteroids • Assessment – Drop in systolic BP > 10 mmHg, rise in pulse > 15 beats / minute on sitting up – 10 to 20% • Supine Hypotension - > 20% • Systolic BP < 100 mmHg / Baseline Tachycardia > 25%

  37. RESUSCITATION • Stabilize BP – 2 large bore IV line – Isotonic saline / Ringer Lactate / fresh blood / packed RBC transfusion – Maintain ½ hour pulse, BP, respiration chart (In emergency situation – O-ve blood) • MEASURE URINE OUTPUT • Correction of coagulopathy – FFP, parenteral Vit K 10 mg • Platelet transfusion – if count < 50,000 • Airway protection – endotracheal intubation to prevent aspiration

  38. RESUSCITATION • Nasal Gastric Aspiration • OCTREOTIDE Infusion 50 to 100 µgm bolus 25 to 50 µgm / hour infusion • VASOPRESSIN 0.3 unit / minute IV – gradually increased to 0.9 units/minute – Side-effects : Myocardial ischemia, infarction, arrhythmia, cardiac arrest, mesenteric ischemia ( now not preferred )

  39. Resuscitation • Endoscopic Therapy : Variceal band ligation Variceal sclerotherapy • Balloon tamponade ( Sengstaken-Blakemore tube or Minnesota tube ) – in pts who cannot get endoscopic therapy or those who need stabilization prior to endoscopic therapy • TIPS – When esophageal varices extend into proximal stomach In Pts eho fail endoscopic / medical treatment and also poor subjects for surgery.

  40. prophylaxis • Beta blockers – propranolol – resting heart rate to be reduced by 25 %. • Repeated variceal band ligation until varices are obliterated.

  41. Splenomegaly & Hypersplenism • Congestive splenomegaly is common in pts with portal htn. • Clinical features include enlarged spleen, thrombocytopenia, leukopenia • Some – significant left sided/ left upper quadrant abdominal pain • No specific treatment • Splenectomy • Hypersplenism with development of thrombocytopenia – first indicator of portal hypertension

  42. Ascites • Accumulation of fluid within the peritoneal cavity • M.C cause : cirrhosis with portal hypertension • Clinical features : increase in abdominal girth peripheral edema dyspnea – if massive bulging flanks shifting dullness fluid thrill • Hepatic hydrothorax – more common on rt.side implicates rent in diaphragm with free flow of ascitic fluid into thoracic cavity

  43. Ascites • Diagnostic paracentesis • SAAG : • >1.1g/dL – portal hypertension • <1.1g/Dl – neoplasm,Tb, pancreatitis, • Ascitic fluid proteins low – high chance of developing SBP • Ascitic fluid – high RBCs – traumatic tap, HCC, ruptured omental varix • Ascitic fluid – PMN >250 /cu.mm - SBP

  44. Ascites - Treatment • Small amounts of ascites – dietary sodium restriction ( <2g/day ) • Moderate : diuretic is essential Spiranolactone 100-200 mg/day OD Furosemide 40-80 mg/day - if peripheral edema + • Pt is compliant but ascitic fluid + , then Spiranolactone 400 -600 mg/day Furosemide 120-160 mg/day • If ascites still + , then it is REFRACTORY ASCITES

  45. Ascites - treatment • Refractory ascites – Large volume paracentesis TIPS Liver Transplantation • Prognosis – pts of cirrhosis with ascites- poor • <50 % of pts survive 2 yrs after the onset of ascites.

  46. Spontaneous Bacterial Peritonitis • Spontaneous infection of ascitic fluid without any intraabdominal source. • Bacterial translocation – gut flora transversing the intestine into mesenteric lymph nodes, leading to bacteremia and seeding of ascitic fluid • MC : E.coli • Others : Step.viridans, Staph.aureus • If > 2 organisms are identified – secondary bacterial peritonitis d/t perforated viscus to be considered • Ascitic fluid PMN > 250/cu.mm

  47. SBP • Pt can present with altered sensorium, elevated WBC, abdominal pain/discomfort • Treatment : cephalosporins • In pts with an episode(s) of SBP and recovered , once –weekly- administration of antibiotic as prophylactic measure

  48. Hepatorenal Syndrome • Functional renal failure without renal pathology • 10% of pts with cirrhosis / advanced liver failure • Diagnosis : presence of large amount of ascites progressive rise in creatinine urinary sodium <10 mEq • Type 1 HRS : progressive impairment of renal function & significant reduction in creatinine clearance within 1- 2 wks . BAD PROGNOSIS • Type 2 HRS : reduction in GFR, with rise in S.Creat BETTER PROGNOSIS

  49. Hepatorenal Syndrome • Seen in refractory ascites • Exclude causes of ARF • Treatment: • Midodrine, an alpha agonist along with Octerotide and IV Albumin • Liver transplantation

More Related